Breast Cancer Clinical Trial
Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer
Summary
This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of disease prior to surgical and oncologic management. The study will investigate any incremental added benefit to breast MRI specificity by the addition of concurrent hybrid breast PET.
Full Description
The study hypothesis is that the combination of Breast PET/MRI, will improve specificity and decrease the number of false positive breast biopsies recommended based on breast MRI findings.
Eligibility Criteria
Inclusion Criteria:
Women over age of 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care
Exclusion Criteria:
Male subjects
Women younger than 25
Pregnant subjects
Unable or unwilling to undergo MRI
Previous adverse reaction to 18F-FDG
Unwilling to undergo biopsy of MRI positive lesions
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10065, United States
How clear is this clinincal trial information?